Page last updated: 2024-11-05

trimetrexate and Allergy, Drug

trimetrexate has been researched along with Allergy, Drug in 2 studies

Trimetrexate: A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.

Research Excerpts

ExcerptRelevanceReference
"Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as an antiparasitic agent against Pneumocystis carinii pneumonia in AIDS patients."1.28Hypersensitivity reactions to trimetrexate. ( Brown, TD; Costanza, ME; Grem, JL; King, SA, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korraa, H1
Saadeh, C1
Grem, JL1
King, SA1
Costanza, ME1
Brown, TD1

Reviews

1 review available for trimetrexate and Allergy, Drug

ArticleYear
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Southern medical journal, 1996, Volume: 89, Issue:3

    Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Ag

1996

Other Studies

1 other study available for trimetrexate and Allergy, Drug

ArticleYear
Hypersensitivity reactions to trimetrexate.
    Investigational new drugs, 1990, Volume: 8, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Drug Hyper

1990